E

Epitomee Medical Ltd
TASE:EPIT

Watchlist Manager
Epitomee Medical Ltd
TASE:EPIT
Watchlist
Price: 947.5 ILS -1.1% Market Closed
Market Cap: 279.6m ILS
Have any thoughts about
Epitomee Medical Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one EPIT stock under the Base Case scenario is 370.35 ILS. Compared to the current market price of 947.5 ILS, Epitomee Medical Ltd is Overvalued by 61%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EPIT Relative Value
Base Case
370.35 ILS
Overvaluation 61%
Relative Value
Price
E
Worst Case
Base Case
Best Case

Valuation Multiples

7.7
P/S
P/S
Price to Sales
7.7
vs History
2
vs Industry
42
Median 3Y
0
Median 5Y
0
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-7.7
Median 5Y
-7.7
Industry
23.1
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-10.5
Median 5Y
-10.5
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-7
Median 5Y
-7
Industry
20.1
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
43
vs Industry
69
Median 3Y
2.5
Median 5Y
2.5
Industry
2.2
More Details
5.2
EV/S
EV/S
Enterprise Value to Sales
5.2
vs History
2
vs Industry
88
Median 3Y
0
Median 5Y
0
Industry
2.4
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
88
Median 3Y
0
Median 5Y
0
Industry
5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
54
Median 3Y
-6.2
Median 5Y
-6.2
Industry
12.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
50
Median 3Y
-5.8
Median 5Y
-5.8
Industry
17.1
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
55
Median 3Y
-6.3
Median 5Y
-6.3
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
45
Median 3Y
-4.5
Median 5Y
-4.5
Industry
18
More Details
11.2
EV/IC
EV/IC
Enterprise Value to IC
11.2
vs History
18
vs Industry
79
Median 3Y
2.3
Median 5Y
2.3
Industry
1.9
More Details

Multiples Across Competitors

EPIT Competitors Multiples
Epitomee Medical Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
Epitomee Medical Ltd
TASE:EPIT
281.9m ILS 7.7 -12.7 -8 -7.5
US
Abbott Laboratories
NYSE:ABT
200.4B USD 4.9 34.7 20.2 29.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
191.7B USD 24.4 85.4 73 90.6
US
Stryker Corp
NYSE:SYK
141.1B USD 6.4 39.3 25.5 31
US
Boston Scientific Corp
NYSE:BSX
134.3B USD 8.5 75 34.3 49.1
IE
Medtronic PLC
NYSE:MDT
104.7B USD 3.2 24.4 13.6 19.3
US
Becton Dickinson and Co
NYSE:BDX
66.2B USD 3.3 38.3 15.8 28.4
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR 2.6 31.2 17.7 25.8
US
Edwards Lifesciences Corp
NYSE:EW
44.4B USD 7.9 10.7 23.7 26
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
308.3B CNY 8.3 24.9 21.6 21.6
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.5B USD 1.9 21.8 13.6 16.8

See Also

Summary
EPIT intrinsic value, competitors valuation, and company profile.
DCF Valuation
EPIT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EPIT stock valuation using valuation multiples.
Wall Street Estimates
EPIT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EPIT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.